With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * In‑depth analysis of the global and regional biosimilars market, including competitive landscapes, pricing dynamics, regulatory trends, and access considerations * Application of AI‑based tools and advanced analytics for market analysis, forecasting, scenario simulation, and decision support - Direct support of the CBO and the Board in strategic planning, portfolio decisions, and ad‑hoc analysis * Several years of senior experience in portfolio management, strategy, market analysis, or corporate development, preferably within biosimilars and generics
mehr